表紙：がん生検市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

市場調査レポート

商品コード

1301441

がん生検市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2023年05月30日 | 発行: Transparency Market Research

| ページ情報: 英文 190 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 915,030円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,388,730円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,862,430円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

がん生検市場- レポートの範囲

世界のがん生検市場に関するTMRの調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も掲載しています。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、がん生検市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートでは、がん生検の競合情勢を詳しく掘り下げています。世界のがん生検市場で活動している主要企業が特定され、これらはさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のがん生検市場のプレーヤーの属性です。

イントロダクションと定義
主な発見/開発
市場価値予測：用途別、2017-2031
- 乳がん
- 結腸直腸がん
- 子宮頸がん
- 肺がん
- 前立腺がん
- 皮膚ガン
- 血液がん
- 腎臓がん
- 肝臓がん
- 膵臓がん
- 卵巣がん
- その他
市場魅力分析：用途別

第9章世界市場の分析と予測：地域別

主な調査結果
市場価値予測：地域別、2017-2031
- 北米
- 欧州
- アジア太平洋地域
- ラテンアメリカ
- 中東・アフリカ
市場魅力分析：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東およびアフリカ市場の分析と予測

第15章競合情勢

市場企業- 競合マトリックス（企業の階層および規模別）
市場シェア分析：企業別、2022年
企業プロファイル
- Abbott Laboratories
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Siemens Healthineers
- GE Healthcare
- Bio-Rad Laboratories, Inc.
- Olympus Corporation
- QIAGEN

図表

List of Tables

Table 01: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 03: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 05: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 06: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 09: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 10: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 11: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 12: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 13: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 16: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 17: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 18: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 19: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 21: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 22: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 23: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 24: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 25: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 27: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 28: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 29: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 30: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 31: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 33: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 34: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 35: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 36: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

List of Figures

Figure 01: Global Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 02: Global Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 03: Global Cancer Biopsy Market Revenue (US$ Mn), by Platforms & Instruments, 2017-2031
Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Kits & Reagents, 2017-2031
Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Services, 2017-2031
Figure 05: Global Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 06: Global Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
Figure 07: Global Cancer Biopsy Market Revenue (US$ Mn), by Tissue Biopsies, 2017-2031
Figure 08: Global Cancer Biopsy Market Revenue (US$ Mn), by Liquid Biopsies, 2017-2031
Figure 09: Global Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 10: Global Cancer Biopsy Market Attractiveness Analysis, Application, 2023-2031
Figure 11: Global Cancer Biopsy Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
Figure 12: Global Cancer Biopsy Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031
Figure 13: Global Cancer Biopsy Market Revenue (US$ Mn), by Cervical Cancer 2022 and 2031
Figure 14: Global Cancer Biopsy Market Revenue (US$ Mn), Lung Cancer, 2023-2031
Figure 15: Global Cancer Biopsy Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031
Figure 16: Global Cancer Biopsy Market Revenue (US$ Mn), by Skin Cancer, 2017-2031
Figure 17: Global Cancer Biopsy Market Revenue (US$ Mn), by Blood Cancer, 2017-2031
Figure 18: Global Cancer Biopsy Market Revenue (US$ Mn), Kidney Cancer, 2023-2031
Figure 19: Global Cancer Biopsy Market Revenue (US$ Mn), by Liver Cancer, 2017-2031
Figure 20: Global Cancer Biopsy Market Revenue (US$ Mn), by Pancreatic Cancer, 2017-2031
Figure 21: Global Cancer Biopsy Market Revenue (US$ Mn), by Ovarian Cancer, 2017-2031
Figure 22: Global Cancer Biopsy Market Revenue (US$ Mn), by Others, 2017-2031
Figure 23: Global Cancer Biopsy Market Value Share Analysis, by Region, 2022 and 2031
Figure 24: Global Cancer Biopsy Market Attractiveness Analysis, by Region, 2023-2031
Figure 25: North America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 26: North America Cancer Biopsy Market Value Share Analysis, by Country, 2022 and 2031
Figure 27: North America Cancer Biopsy Market Attractiveness Analysis, by Country, 2023-2031
Figure 28: North America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 29: North America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 30: North America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 31: North America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
Figure 32: North America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 33: North America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 34: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 35: Europe Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 37: Europe Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 38: Europe Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 39: Europe Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 40: Europe Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
Figure 41: Europe Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 42: Europe Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 43: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 44: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 46: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 47: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 48: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 49: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
Figure 50: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 51: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 52: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 53: Latin America Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 54: Latin America Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 55: Latin America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 56: Latin America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 57: Latin America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 58: Latin America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
Figure 59: Latin America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 60: Latin America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 61: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 62: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 63: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 64: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 65: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 66: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 67: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
Figure 68: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 69: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 70: Global Cancer Biopsy Market Share Analysis, by Company 2022

Product Code: TMRGL85628

Cancer Biopsy Market - Scope of Report

TMR's report on the global Cancer Biopsy Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Cancer Biopsy Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Cancer Biopsy Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Cancer Biopsy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Cancer Biopsy.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Cancer Biopsy. These serve as valuable tools for existing market players as well as for entities interested in participating in the Cancer Biopsy.

The report delves into the competitive landscape of the Cancer Biopsy. Key players operating in the global Cancer Biopsy Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Cancer Biopsy Market profiled in this report.

Key Questions Answered in Global Cancer Biopsy Market Report:

What is the sales/revenue generated by Cancer Biopsy across all regions during the forecast period?
What are the opportunities in the Cancer Biopsy?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Cancer Biopsy Market - Research Objectives and Research Approach

The comprehensive report on the global Cancer Biopsy Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Cancer Biopsy Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the Cancer Biopsy.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Biopsy Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Cancer Biopsy Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Cancer Prevalence & Incidence, by Region
5.2. Technological Advancements
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
5.4. Reimbursement Scenario by Region/Globally
5.5. Value Chain Analysis

6. Global Cancer Biopsy Market Analysis and Forecast, by Product

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Platforms & Instruments
- 6.3.2. Kits & Reagents
- 6.3.3. Services
6.4. Market Attractiveness Analysis, by Product

7. Global Cancer Biopsy Market Analysis and Forecast, by Type

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type, 2017-2031
- 7.3.1. Tissue Biopsies
  - 7.3.1.1. Needle Biopsies
  - 7.3.1.2. Surgical Biopsies
- 7.3.2. Liquid Biopsies
- 7.3.3. Others
7.4. Market Attractiveness Analysis, by Type

8. Global Cancer Biopsy Market Analysis and Forecast, by Application

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
- 8.3.1. Breast Cancer
- 8.3.2. Colorectal Cancer
- 8.3.3. Cervical Cancer
- 8.3.4. Lung Cancer
- 8.3.5. Prostate Cancer
- 8.3.6. Skin Cancer
- 8.3.7. Blood Cancer
- 8.3.8. Kidney Cancer
- 8.3.9. Liver Cancer
- 8.3.10. Pancreatic Cancer
- 8.3.11. Ovarian Cancer
- 8.3.12. Others
8.4. Market Attractiveness Analysis, by Application

9. Global Cancer Biopsy Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Cancer Biopsy Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Platforms & Instruments
- 10.2.2. Kits & Reagents
- 10.2.3. Services
10.3. Market Value Forecast, by Type, 2017-2031
- 10.3.1. Tissue Biopsies
  - 10.3.1.1. Needle Biopsies
  - 10.3.1.2. Surgical Biopsies
- 10.3.2. Liquid Biopsies
- 10.3.3. Others
10.4. Market Value Forecast, by Application, 2017-2031
- 10.4.1. Breast Cancer
- 10.4.2. Colorectal Cancer
- 10.4.3. Cervical Cancer
- 10.4.4. Lung Cancer
- 10.4.5. Prostate Cancer
- 10.4.6. Skin Cancer
- 10.4.7. Blood Cancer
- 10.4.8. Kidney Cancer
- 10.4.9. Liver Cancer
- 10.4.10. Pancreatic Cancer
- 10.4.11. Ovarian Cancer
- 10.4.12. Others
10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Type
- 10.6.3. By Application
- 10.6.4. By Country

11. Europe Cancer Biopsy Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Platforms & Instruments
- 11.2.2. Kits & Reagents
- 11.2.3. Services
11.3. Market Value Forecast, by Type, 2017-2031
- 11.3.1. Tissue Biopsies
  - 11.3.1.1. Needle Biopsies
  - 11.3.1.2. Surgical Biopsies
- 11.3.2. Liquid Biopsies
- 11.3.3. Others
11.4. Market Value Forecast, by Application, 2017-2031
- 11.4.1. Breast Cancer
- 11.4.2. Colorectal Cancer
- 11.4.3. Cervical Cancer
- 11.4.4. Lung Cancer
- 11.4.5. Prostate Cancer
- 11.4.6. Skin Cancer
- 11.4.7. Blood Cancer
- 11.4.8. Kidney Cancer
- 11.4.9. Liver Cancer
- 11.4.10. Pancreatic Cancer
- 11.4.11. Ovarian Cancer
- 11.4.12. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Type
- 11.6.3. By Application
- 11.6.4. By Country/Sub-region

12. Asia Pacific Cancer Biopsy Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Instruments
- 12.2.2. Kits & Reagents
- 12.2.3. Services
12.3. Market Value Forecast, by Type, 2017-2031
- 12.3.1. Tissue Biopsies
  - 12.3.1.1. Needle Biopsies
  - 12.3.1.2. Surgical Biopsies
- 12.3.2. Liquid Biopsies
- 12.3.3. Others
12.4. Market Value Forecast, by Application, 2017-2031
- 12.4.1. Breast Cancer
- 12.4.2. Colorectal Cancer
- 12.4.3. Cervical Cancer
- 12.4.4. Lung Cancer
- 12.4.5. Prostate Cancer
- 12.4.6. Skin Cancer
- 12.4.7. Blood Cancer
- 12.4.8. Kidney Cancer
- 12.4.9. Liver Cancer
- 12.4.10. Pancreatic Cancer
- 12.4.11. Ovarian Cancer
- 12.4.12. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Type
- 12.6.3. By Application
- 12.6.4. By Country/Sub-region

13. Latin America Cancer Biopsy Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Platforms & Platforms & Instruments
- 13.2.2. Kits & Reagents
- 13.2.3. Services
13.3. Market Value Forecast, by Type, 2017-2031
- 13.3.1. Tissue Biopsies
  - 13.3.1.1. Needle Biopsies
  - 13.3.1.2. Surgical Biopsies
- 13.3.2. Liquid Biopsies
- 13.3.3. Others
13.4. Market Value Forecast, by Application, 2017-2031
- 13.4.1. Breast Cancer
- 13.4.2. Colorectal Cancer
- 13.4.3. Cervical Cancer
- 13.4.4. Lung Cancer
- 13.4.5. Prostate Cancer
- 13.4.6. Skin Cancer
- 13.4.7. Blood Cancer
- 13.4.8. Kidney Cancer
- 13.4.9. Liver Cancer
- 13.4.10. Pancreatic Cancer
- 13.4.11. Ovarian Cancer
- 13.4.12. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Type
- 13.6.3. By Application
- 13.6.4. By Country/Sub-region

14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Platforms & Instruments
- 14.2.2. Kits & Reagents
- 14.2.3. Services
14.3. Market Value Forecast, by Type, 2017-2031
- 14.3.1. Tissue Biopsies
  - 14.3.1.1. Needle Biopsies
  - 14.3.1.2. Surgical Biopsies
- 14.3.2. Liquid Biopsies
- 14.3.3. Others
14.4. Market Value Forecast, by Application, 2017-2031
- 14.4.1. Breast Cancer
- 14.4.2. Colorectal Cancer
- 14.4.3. Cervical Cancer
- 14.4.4. Lung Cancer
- 14.4.5. Prostate Cancer
- 14.4.6. Skin Cancer
- 14.4.7. Blood Cancer
- 14.4.8. Kidney Cancer
- 14.4.9. Liver Cancer
- 14.4.10. Pancreatic Cancer
- 14.4.11. Ovarian Cancer
- 14.4.12. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Type
- 14.6.3. By Application
- 14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
- 15.3.1. Abbott Laboratories
  - 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. Financial Overview
  - 15.3.1.4. SWOT Analysis
  - 15.3.1.5. Strategic Overview
- 15.3.2. Becton, Dickinson and Company
  - 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. Financial Overview
  - 15.3.2.4. SWOT Analysis
  - 15.3.2.5. Strategic Overview
- 15.3.3. F. Hoffmann-La Roche Ltd.
  - 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. Financial Overview
  - 15.3.3.4. SWOT Analysis
  - 15.3.3.5. Strategic Overview
- 15.3.4. Hologic, Inc.
  - 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. Financial Overview
  - 15.3.4.4. SWOT Analysis
  - 15.3.4.5. Strategic Overview
- 15.3.5. Danaher Corporation
  - 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. Financial Overview
  - 15.3.5.4. SWOT Analysis
  - 15.3.5.5. Strategic Overview
- 15.3.6. Thermo Fisher Scientific, Inc.
  - 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. Financial Overview
  - 15.3.6.4. SWOT Analysis
  - 15.3.6.5. Strategic Overview
- 15.3.7. Agilent Technologies, Inc.
  - 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. Financial Overview
  - 15.3.7.4. SWOT Analysis
  - 15.3.7.5. Strategic Overview
- 15.3.8. Illumina, Inc.
  - 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. Financial Overview
  - 15.3.8.4. SWOT Analysis
  - 15.3.8.5. Strategic Overview
- 15.3.9. Siemens Healthineers
  - 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. Financial Overview
  - 15.3.9.4. SWOT Analysis
  - 15.3.9.5. Strategic Overview
- 15.3.10. GE Healthcare
  - 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.10.2. Product Portfolio
  - 15.3.10.3. Financial Overview
  - 15.3.10.4. SWOT Analysis
  - 15.3.10.5. Strategic Overview
- 15.3.11. Bio-Rad Laboratories, Inc.
  - 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.11.2. Product Portfolio
  - 15.3.11.3. Financial Overview
  - 15.3.11.4. SWOT Analysis
  - 15.3.11.5. Strategic Overview
- 15.3.12. Olympus Corporation
  - 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.12.2. Product Portfolio
  - 15.3.12.3. Financial Overview
  - 15.3.12.4. SWOT Analysis
  - 15.3.12.5. Strategic Overview
- 15.3.13. QIAGEN
  - 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.13.2. Product Portfolio
  - 15.3.13.3. Financial Overview
  - 15.3.13.4. SWOT Analysis
  - 15.3.13.5. Strategic Overview

がん生検市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

がん生検市場- レポートの範囲

目次

第1章序文

第2章仮定と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：製品別

第7章世界市場の分析と予測：タイプ別

第8章世界市場の分析と予測：用途別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東およびアフリカ市場の分析と予測

第15章競合情勢

List of Tables

List of Figures

Cancer Biopsy Market - Scope of Report

Key Questions Answered in Global Cancer Biopsy Market Report:

Cancer Biopsy Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Biopsy Market

4. Market Overview

5. Key Insights

6. Global Cancer Biopsy Market Analysis and Forecast, by Product

7. Global Cancer Biopsy Market Analysis and Forecast, by Type

8. Global Cancer Biopsy Market Analysis and Forecast, by Application

9. Global Cancer Biopsy Market Analysis and Forecast, by Region

10. North America Cancer Biopsy Market Analysis and Forecast

11. Europe Cancer Biopsy Market Analysis and Forecast

12. Asia Pacific Cancer Biopsy Market Analysis and Forecast

13. Latin America Cancer Biopsy Market Analysis and Forecast

14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast

15. Competition Landscape

がん生検市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

がん生検市場- レポートの範囲

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

第5章 重要な洞察

第6章 世界市場の分析と予測：製品別

第7章 世界市場の分析と予測：タイプ別

第8章 世界市場の分析と予測：用途別

第9章 世界市場の分析と予測：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東およびアフリカ市場の分析と予測

第15章 競合情勢

List of Tables

List of Figures

Cancer Biopsy Market - Scope of Report

Key Questions Answered in Global Cancer Biopsy Market Report:

Cancer Biopsy Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Biopsy Market

4. Market Overview

5. Key Insights

6. Global Cancer Biopsy Market Analysis and Forecast, by Product

7. Global Cancer Biopsy Market Analysis and Forecast, by Type

8. Global Cancer Biopsy Market Analysis and Forecast, by Application

9. Global Cancer Biopsy Market Analysis and Forecast, by Region

10. North America Cancer Biopsy Market Analysis and Forecast

11. Europe Cancer Biopsy Market Analysis and Forecast

12. Asia Pacific Cancer Biopsy Market Analysis and Forecast

13. Latin America Cancer Biopsy Market Analysis and Forecast

14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast

15. Competition Landscape

第1章序文

第2章仮定と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：製品別

第7章世界市場の分析と予測：タイプ別

第8章世界市場の分析と予測：用途別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東およびアフリカ市場の分析と予測

第15章競合情勢